Literature DB >> 31872435

Power analysis for cluster randomized trials with multiple binary co-primary endpoints.

Dateng Li1, Jing Cao1, Song Zhang2.   

Abstract

Cluster randomized trials (CRTs) are widely used in different areas of medicine and public health. Recently, with increasing complexity of medical therapies and technological advances in monitoring multiple outcomes, many clinical trials attempt to evaluate multiple co-primary endpoints. In this study, we present a power analysis method for CRTs with K ≥ 2 binary co-primary endpoints. It is developed based on the GEE (generalized estimating equation) approach, and three types of correlations are considered: inter-subject correlation within each endpoint, intra-subject correlation across endpoints, and inter-subject correlation across endpoints. A closed-form joint distribution of the K test statistics is derived, which facilitates the evaluation of power and type I error for arbitrarily constructed hypotheses. We further present a theorem that characterizes the relationship between various correlations and testing power. We assess the performance of the proposed power analysis method based on extensive simulation studies. An application example to a real clinical trial is presented.
© 2019 The International Biometric Society.

Keywords:  binary; cluster randomized trials; multiple co-primary endpoints; power analysis; sample size

Year:  2020        PMID: 31872435     DOI: 10.1111/biom.13212

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  2 in total

1.  Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.

Authors:  Monica Taljaard; Fan Li; Bo Qin; Caroline Cui; Leyi Zhang; Stuart G Nicholls; Kelly Carroll; Susan L Mitchell
Journal:  Clin Trials       Date:  2021-11-29       Impact factor: 2.486

2.  Sample size calculation in hierarchical 2 × 2 factorial trials with unequal cluster sizes.

Authors:  Zizhong Tian; Denise Esserman; Guangyu Tong; Ondrej Blaha; James Dziura; Peter Peduzzi; Fan Li
Journal:  Stat Med       Date:  2022-01-02       Impact factor: 2.373

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.